Chapter 9 PHARMACOKINETICS VARIABILITY

Slides:



Advertisements
Similar presentations
Pages 645 to 724 Mechanisms of Drug Interaction Pharmacokinetic –Reduced rate and/or completeness of absorption –Altered bioavailabilty –Reduced.
Advertisements

Pharmacology for Anesthesia I Introduction. What is a Drug?
Flucoral® Pharmacological Composition Each capsule containing 150mg Fluconazole. Fluconazole is a broad spectrum Systemic Antifungal.
Dosage Regimen Design in Patients with Renal Insufficiency Cont’d Pharmacy 732 Winter, 2001.
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Pharmacokinetics Chapter 4.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 10 Drug Therapy in Pediatric Patients.
Factors Affecting Drug Activity Chapter 11 Pages
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Clinical Pharmacy Part 2
Orientation to Pharmacology
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
Bioavailability Dr Mohammad Issa.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
VARIABILITY IN PHARMACOKINETICS & PATIENT RESPONSE Dr. Mohd B. Makmor Bakry, Ph.D., RPh Senior Lecturer in Clinical Pharmacy Universiti Kebangsaan Malaysia.
Introduction to Pharmacology. ORIENTATION TO PHARMACOLOGY Objectives: 1. Definition of the four basic terms (drug, pharmacology, clinical pharmacology,
INTRODUCTION CLINICAL PHARMACOKINETICS
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Copyright ©2008 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Focus on Pharmacology, First Edition By Jahangir Moini.
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Principles of Drug Action.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Donepezil. Donepezil Generic name: Donepezil. Brand name: Aricept. Chemistry: Donepezil hydrochloride is a piperidine derivative. It is a white crystalline.
Foundation Knowledge and Skills
Drug efficacy is questioned.. Variation in drug responses.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
Pharmacology I Session One Pharmacological Principles.
Genotype-directed dosing for Efavirenz
Drug therapy in pediatric
Tina Kochupurackal, D.O., Barry Hoffman, D.O.
Chapter 5 Drug Metabolism
Pharmacokinetics and Pharmacodynamics
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Life Span Consideration
Factors Affecting Drug Activity
Drug Therapy in Geriatric Patients
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
BTP 3822 BIOPHARMACEUTICS Quiz I
BTP3822 BIOPHARMACEUTICS by
Anticonvulsants: Valproic acid
Understanding the Basics of Pharmacology
Drug Therapy in Pediatric Patients
Mahla sattarzadeh Kerman University of Medical Sciences
Factors affecting Drug Activity
Biopharmaceutics Dr Mohammad Issa Saleh.
PHARMACY TECHNICIAN CHAPTER NINETEEN.
Introduction; Scope of Pharmacology Routes of Drug Administration
Orientation to Pharmacology
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Clinical Pharmacokinetics
Pharmacokinetics and Factors of Individual Variation
Clinical Pharmacokinetics
Dose measurement Lecturer: dr. Asmaa abdelaziz Mohamed
Basic Biopharmaceutics
Individual Variation in Drug Responses
Therapeutic Drug Monitoring chapter 1 part 1
Clinical Pharmacokinetics
Therapeutic Drug Monitoring
Introduction to Pharmacogenetics
Medication Administration for Pediatrics
Drug Therapy in Pediatric Patients
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
POLYPHARMACY.
Presentation transcript:

Chapter 9 PHARMACOKINETICS VARIABILITY by Dr. Arshad Ali Khan Faculty of Engineering Technology arshad@ump.edu.my

PHARMACOKINETICS VARIABILITY Definition : Due to differences in drug concentration at the site of action because of inter-individual differences in drug absorption, distribution, metabolism and excretion. Also known as inter-individual variations of a drugs pharmacokinetic parameters, resulting in different pharmacokinetic profiles after administration of the same dose to different patients.

FACTORS AFFECTING THE PHARMACOKINETIC VARIABILITY IN DISEASES STATES

Body weight Same drug dose administration with different body weight individuals may results into different plasma profile The dose adjustment according to the body weigh individual (obese and thin) can reduce the pharmacokinetic variability. In the obese patients, it is difficult to reduce the pharmacokinetic variability of drug because the recommended dose of the drugs are normally based on the body weight of the normal individuals. This pharmacokinetic variability is due to the function of organs such as kidney and liver is different from the normal individuals.

Elderly subjects (more than 70 years) Age Age can affect the distribution and elimination of drugs Drug protein binding, drug metabolism and drug excretion may change according to age There are 5 groups : Infants (1-12 months) Newborns (-3 days) AGE Children (4-9 years) Adults (16-37years) Elderly subjects (more than 70 years)

Sex The body size are different for both men and women which led to different volume of distribution and different drug clearance. Higher body fat in female may enhance the volume of distribution for the lipophilic therapeutic agents. The oral bioavailability in somewhat higher in female in comparison to male. Bioavailability after transdermal drug administration does not appear to be significantly affected by gender; nor does protein binding. The transdermal drug administration are not affected by sex.

References References Wyatt, C. M., Kim, M. C., & Winston, J. A. (2006). Therapy Insight: How Changes in Renal Function With Increasing Age Affect Cardiovascular Drug Prescribing. Retrieved from Nat Clin Pract Cardiovasc Med: http://www.medscape.com/viewarticle/522929_4 S.M. Hanning, J. M.-G. (2015, february 1). Investigation into the dosage form attributes of currently UK licensed cardiovascular and parkinson's disease drug products. Retrieved from science direct: http://www.Sciencedirect.Com/science/article/pii/S0378517314009624 Pharmacokinetic variability. (2011, march 29). Retrieved from slide share: http://www.Slideshare.Net/9993664147/pharmacokinetic-variability Pharmacokinetic variability. (N.D.). Retrieved from http://sepia.Unil.Ch/: http://sepia.Unil.Ch/pharmacology/index.Php?Id=78 Mick, R. (N.D.). Drug interactions. Retrieved from www.Wiley.Com: http://www.Wiley.Com/legacy/wileychi/eob/pdfs/eob2_drug.Pdf Philip R orlander, M. (2016, 12 july). Hypothyroidism treatment & management. Retrieved from emedicine.Medscape.Com: http://emedicine.Medscape.Com/article/122393-treatment References

Ötles, S. (2014). Food and drug interactions. Acta sci. Pol. , Technol Ötles, S. (2014). Food and drug interactions. Acta sci. Pol., Technol. Aliment. Retrieved from http://www.Food.Actapol.Net/pub/8_1_2014.Pdf Schwartz, J. B. (2003). The influence of sex on pharmacokinetics. Clinical pharmacokinetics, 42(2), 107-121. https://www.ncbi.nlm.nih.gov/pubmed/12537512 Mangoni, A. A., & Jackson, S. H. (2004). Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. British journal of clinical pharmacology, 57(1), 6-14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884408/ De Baerdemaeker, L. E., Mortier, E. P., & Struys, M. M. (2004). Pharmacokinetics in obese patients. Continuing Education in Anaesthesia, Critical Care & Pain, 4(5), 152-155. http://ceaccp.oxfordjournals.org/content/4/5/152.full Belle, D. J., & Singh, H. (2008). Genetic factors in drug metabolism. American family physician, 77(11). https://www.openanesthesia.org/aba_pharmacokinetics_-_genetic_variability/

Thank you